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Sample:	 Three	 hundred	 randomly	 selected	 runners	
parPcipated	in	the	tesPng	(212	men	and	88	women)	from	
15	diﬀerent	races	in	Europe	between	2012	and	2016.		




to	 idenPfy	 levels	 of	 total	 IgA	 in	 saliva	 (determined	 by	
ELISA)	 and	 levels	 of	 fucosylated	 and	 sialylated	 IgA	
(determined	 by	 lecPn-ELISA)	 and	 how	 inﬂuence	 the	
supplementaPon	of	Ambrotose®	gliconutrients	[1].		
• Ultra	 Cavalls	 del	 Vent	 (100km):	Venous	 blood	 samples	
were	drawn	from	the	antecubital	vein	at	rest	in	a	simng	
posiPon	 and	 collected	 into	 PAXgene	 Blood	 RNA	 Tubes	
and	serum	tubes	to	clot	and	then	were	centrifuged	[2].	
• Camí	 de	 Caval ls	 (185km):	 Tetra-polar	 L -BIA	
measurements	 at	 50	 kHz	 with	 phase-sensiPve	 analyzer	
(BIA-101	Anniversary	Sport	EdiPon;	AKERN-Srl,	Florence,	
Italy),	were	made	on	the	right	and	leb	calf	[3].	
• Volta	 Cerdanya	 (85km):	 ECG	 analysis	 consisted	 of	
standard	 and	 speckle	 tracking	 echocardiographic	
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Conclusions	
• A	 high	 incidence	 of	 respiratory	 infecPons	 aber	 a	
marathon	 were	 observed.	 However,	 parPcipants	 with	
Ambrotose®	 had	 a	 trend	 to	 develop	 lower	 respiratory	
infecPons.	
• Elite	performance	is	mainly	related	with	training.	We	can	





• Some	 individuals	 showed	 worse	 RV	 adaptaPon	 during	
exercise	independent	from	the	training	volume	done	or	
the	elite	proﬁle.
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